By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
Sun Pharmaceutical
-
November 11, 2019, Monday
Sun Pharmaceutical bullish on Japanese market as peers lose interest
Most Indian players have exited Japan over the past decade. Ranbaxy was one of the early entrants.
-
October 14, 2019, Monday
Sun Pharmaceutical launches Cequa to treat dry eye disease in US market
Cequa is indicated to increase tear production in patients with dry eye, Sun Pharma said
-
August 18, 2019, Sunday
Sun Pharmaceutical's US specialty ramp-up still slow, say experts
Sun's focus on specialty comes at a time when its US revenues are under pressure owing to competitive intensity
-
August 14, 2019, Wednesday
Sun Pharma signs global licensing pact with CSIR-IICT for patents
The pact is for patents related to certain compounds with potential therapeutic activity across multiple indications
-
July 31, 2019, Wednesday
Sun Pharma aims to clock 'low-to-mid teens' growth in revenues in FY20
Drug major Sun Pharmaceutical Industries is gradually ramping up its speciality business across global markets as it aims to ...
-
June 20, 2019, Thursday
Sun Pharmaceutical gets four observations for Halol facility in Gujarat
The regulator has also observed that lab control mechanisms were not documented
-
December 03, 2018, Monday
Sun Pharma says need more clarity from Sebi about whistle-blower complaint
Sebi has received a 150-page letter in which a whistle-blower has accused the company of committing corporate governance and ...
-
August 28, 2018, Tuesday
US drug regulator inspects Sun Pharmaceutical's Halol plant in Gujarat
Sun Pharma had recalled around 5,000 units of 10 ml vials of testosterone cypionate injections from the US
-
August 14, 2018, Tuesday
Earnings upgrades ahead for Sun Pharmaceutical, stock gains nearly 7%
US growth at 8%, despite declining Taro sales, giving confidence that the firm is on a recovery path in America
-
December 06, 2017, Wednesday
No major respite for Sun Pharma
The Sun Pharmaceutical stock, after seeing some gains post September quarter results, is now marginally below pre-result levels ...